dostarlimab,pembrolizumab
gsk,merck
['nsclc', 'sclc', 'perla trial', 'pembro']
i often say no head 2 head . not true has presented today at the #esmoimmuno22 a rando phase ii chemo+dosta vs chemo+pembro in #nsclc.there are diff, first time ever. any thought fellas? 
Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own